BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Wei Yang, Yingying Liu, Ruoling Gao, Zenghe Xiu, Ting Sun. Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistanceCellular Signalling 2019; 60: 122 doi: 10.1016/j.cellsig.2019.04.011
2
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experienceAnnals of Gastroenterological Surgery 2020;  doi: 10.1002/ags3.12316
3
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgeryExpert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
4
Xi-Zhen Chen, Wei Kevin Zhang, He-Bin Tang, Xiao-Jun Li, Gui-Hua Tian, Hong-Cai Shang, Yu-Sang Li. The Ethanol Supernatant Extracts of Liushenwan Could Alleviate Nanodiethylnitrosamine-Induced Liver Cancer in MiceCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6934809
5
Eric vanSonnenberg, Peter R. Mueller. Complex Therapeutic Strategies for Hepatocellular Carcinoma: Expanding CriteriaRadiology 2019; 293(3): 716 doi: 10.1148/radiol.2019192151